Fatty Acid Supplementation in Children With ASD

The requested reference [3910554893f7a53bc9a8872025790265d0f1ae6c] no longer exists in our database. It has been replaced by the current reference: [a09c2851190f47023e24683b951d4bb7c6766310]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Children with Autism Spectrum Disorder (ASD) suffer from both mental and physical symptoms that affect their quality of life and severely disrupt family well‐being. Fatty acid supplements are natural products with anti‐inflammatory properties often used for treatment of ASD symptoms, but their efficacy remains unproven. The objective of the proposed protocol is to quantify the impact of Omega 3‐6 on pre‐specified biological signatures. The hypotheses were formulated based on data from the investigators previous studies and other published data which suggest that the inflammatory markers, IL‐1β, IL‐2, and IFNγ are consistently elevated in children with ASD and decreases in these markers correlate with ASD symptom improvement. The investigators long‐term goal is to identify effective treatments for ASD.
Epistemonikos ID: cca2bb18c5a125077ae0c13cad7984bd4936faea
First added on: May 21, 2024